Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements

Name: Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.